Prema Cellars Cabernet Sauvignon Reserve Calistoga 2019, Rick James Nephew, Saltgrass Shrimp Stuffed Jalapenos, Universal Logistics Lawsuit, Nypd Deputy Commissioner, Articles A

Specialty, Ltd. Austin, TX- 503A Facility - Out of business, J & F International Inc.(dba Alexandria Medical Arts Pharmacy & Compounding Laboratory), Alexandria, VA- 503A Facility, Jack P. Herick Inc. (dba Glades Drugs), Pahokee, FL- 503A Facility, Jacobs Pills Inc. (dba The Healthy Choice Apothecary), Elmsford, NY- 503A Facility, Jajco Inc. (dba Anchor Drugs Pharmacy), South San Francisco, CA- 503A Facility, JCB Laboratories, LLC, Wichita, KS- 503A Facility - Out of business, JD & SN Inc. (dba Moses Lake Professional Pharmacy), Moses Lake, WA- 503A Facility, Jeffreys Drug Store, Canonsburg, PA- 503A Facility, Joe Wise Pharmacy, Inc., (dba Wise Pharmacy), Littleton, CO- 503A Facility - Out of business, John Hollis Pharmacy, (see John W. Hollis, Inc.), Nashville, TN- 503A Facility, John W. Hollis, Inc.(dba John Hollis Pharmacy), Nashville, TN- 503A Facility, John L. McClellan Memorial Veterans Hospital, Little Rock, AR- 503A Facility, John's Pharmacy, Inc.,(dba The Sullivan Pharmacy), Sullivan, IL- 503A Facility, Johns Pharmacy LLLP, Cape Girardeau, MO- 503A Facility, Johnson Compounding and Wellness,(see Merissa Corp.), Waltham, MA- 503A Facility, Johnson Memorial Cancer Center, Enfield, CT- 503A Facility, Jones Drug Company, Inc., (dba Reed's Compounding Pharmacy), Tucson, AZ- 503A Facility, Jubilant DraxImage Radiopharmacies, Inc., (dba Triad Isotopes, Inc.), Kansas City, MO- 503A Facility, Jubilant HollisterStier, LLC, Spokane, WA- 503A Facility - De-registered as an Outsourcing Facility, Jungle Jim's Pharmacy, Fairfield, OH- 503A Facility, J.W. [21-30534] REVIEWED AND/OR EDITED - The original text prior to review appeared as follows: UNOPPOSED MOTION filed by Appellant Mr. Randy Denning to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. Randy DENNING, PlaintiffAppellant, v. BOND PHARMACY, INCORPORATED, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, DefendantAppellee. For the following reasons, the Court denies the motion. Our inspiration came from the infusion experiences of our close family: Annette's brother and Lucien's father. Court: Id. Transcript Order ddl satisfied. Published: June 7, 2022 Categorized as: imprisonment 5e dndbeyond . (Entered: 03/04/2021), Docket(#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. BCBS and AHS (collectively "Counter-Plaintiffs") answered and asserted a counterclaim against AIS, stating claims of breach of contract, misrepresentation, breach of the duty of good faith and fair dealing, and unjust enrichment, as well as seeking declaratory relief that BCBS has no contractual obligation to pay the unpaid claims. may be available from PACER. Admitted Exhibits on File in District Court? Advanced Infusion Solutions (BOND PHARMACY INC) is a Home Infusion Therapy Pharmacy in Dallas, Texas. Transcript order due on 09/23/2021, for Appellant Randy Denning. (LSau) (Entered: 04/06/2021), Docket(#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. The Court will address each in turn. 2009). [21-30534] (See Fifth Circuit's order transmitted separately this date) (AGL) [Entered: 10/22/2021 08:24 AM], The Motion to supplement the record on appeal filed by Appellant Mr. Randy Denning in 21-30534 [ # 9692325-2 ] has been made sufficient. [21-30534] (DDL) [Entered: 09/17/2021 02:02 PM], ELECTRONIC RECORD ON APPEAL FILED. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. 2008). Advanced Infusion Solutions. 19 Guaynabo, PR 00966 Phone (787) 783-2245 Fax (787) 523-1178 / (787) 781-8384. Spokeo, 578 U.S. at 340-41). may be available from PACER. 2201. Yes. Action: Case OK to Process. 18008 Bothell Everett Hwy SE # F, Bothell, WA 98012. Supplemental Electronic ROA due on 11/08/2021. Click the citation to see the full text of the cited case. [47] 38. (Cloutier, Kevin) (Entered: 04/29/2021), (#21) RESPONSE to #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Blue Cross Blue Shield of Michigan. Release of Transcript Restriction set for 10/4/2021. Removed To Federal Court Counsel at Phelps Dunbar and Sheppard, Mullin, Richter & Hampton on Friday removed a breach-of-contract class action lawsuit against Bond Pharmacy, Advanced Infusion. Then, BCBS and AHS terminated the Agreement with AIS by providing timely notice per the Agreement's terms. Industry: Health maintenance organization , Drug stores and proprietary stores Printer Friendly View Address: 623 Highland Colony Pkwy Ste 100 Ridgeland, MS, 39157-6077 United States See other locations Phone: Website: www.aiscaregroup.com Employees (this site): Actual ESG industry average: What is D&B's ESG Ranking? Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare, SUPPLEMENTAL ELECTRONIC RECORD ON APPEAL FILED. Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. 2:23-CV-00124 | 2023-01-31, U.S. District Courts | Property | The medication in the pump lasts between a week and several months without requiring the patient to see a healthcare provider. Document is insufficient for the following reasons: Motion does not contain a Certificate of Compliance. If no request is filed, the transcript may be made remotely electronically available to the public without redaction after 90 days. Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. Id. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), (#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) Id. Warm blankets . R. Civ. Steury v. Cardinal Health, Inc.,625 F.3d 262, 266 (5th Cir. [57] at 16. County of 1st Plaintiff: Wayne - County Where Action Arose: Wayne - County of 1st Defendant: Out of State. See AIS's Memo. Receipt No: AMIEDC-8266539 - Fee: $ 402. [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 04:00 PM], APPEARANCE FORM for the court's review. Advanced Infusion Care Our divisions Setting new quality standards in our pharmacies At our state-of-the-art pharmacies, we go beyond state and industry standards to produce patient-specific prescriptions of the highest quality and sterility. 2010) (cleaned up). Rule 9(b) requires a party to plead with particularity the circumstances constituting fraud. A more recent docket listing [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021), U.S. Courts Of Appeals | Contract | Descubrir Personas Learning Empleos Unirse ahora . Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. Because BCBS and AHS may plead unjust enrichment in the alternative, the Court does not dismiss this claim. [21-30534] (Beau Camel ) [Entered: 09/28/2021 10:10 AM], APPEARANCE FORM FILED by Attorney(s) Beau Camel for party(s) Appellant Randy Denning, in case 21-30534. Cause No. Compl. Why is this public record being published online? D/B/A ADVANCED INFUSION CARE Court:United States District Court, Eastern District of Louisiana Date published: Jul 30, 2021 CitationsCopy Citation Civil Action 21-774 (E.D. . Listed below are the cases that are cited in this Featured Case. Platt, RPh LLC. Ct. App. Advanced Infusion Solutions (AIS) Fabricacin de productos farmacuticos Ridgeland, Mississippi MMM Holdings LLC . for a lawsuit in American courts[. 1 star. Flaherty & Crumrine Preferred Income Fund Inc. v. TXU Corp.,565 F.3d 200, 206-07 (5th Cir. If you are not a monthly . Owned by: Advanced Infusion Solutions Acquisition, LLC Serial Number: 87399535. 47. In other words, unjust enrichment only applies when: "[(1)] there is no legal contract and [(2)] the person sought to be charged is in possession of money or property which in good conscience and justice he should not retain but should deliver to another." Mailing Address: PMB 507 1353 Rd. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. Date of service: 10/19/2021. Id. Lead Counsel? Plaintiff / Appellant: Randy Denning. P. 9(b). 03/16/2022. See Fed. BCBS and AHS allege they "entered into the Agreement for the purpose of contracting with AIS to provide home infusion therapy services to its members pursuant to the terms of the Agreement." Signed by District Judge Denise Page Hood. [21-30534] (Paul Anthony Werner III) [Entered: 09/13/2021 03:26 PM], APPEARANCE FORM for the court's review. 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | These allegations are sufficient to plausibly state a claim for breach of good faith and fair dealing. Yes. Doesn't sound . Subscribe to Justia's Free Newsletters featuring summaries of federal and state court opinions. The Court therefore denies AIS's motion on this claim. Id. Sufficient Mtn/Resp/Rpl deadline satisfied. In-Office Appointments. View contact profiles from AIS Healthcare Popular Searches Ais Healthcare Ais Healthcare LLC Motion Hearing set for 6/23/2021 04:00 PM before District Judge Denise Page Hood |Zoom Webinar Information: https://www.zoomgov.com/j/1616326086?pwd=dTVZRnlseVBTNFRhNVE0SlhQaEozUT09 Passcode: 999999 Or One tap mobile : US: +16692545252,,1616326086# or +16468287666,,1616326086#| (LSau) (Entered: 05/11/2021), (#22) NOTICE of Appearance by Kevin M. Cloutier on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. [47] 54. Id. BOND PHARMACY d/b/a, ADVANCED INFUSION SOLUTIONS Plaintiff, [47] 32. AIS is a specialty pharmacy that provides home infusion therapy, which infuses patients' pain medications into the intrathecal space surrounding their spinal cord through surgically implanted pumps. Mississippi, Northern Division. See Se Med. Founders Chuck Bell Operating Status Active Company Type For Profit Phone Number 601.988.1700 AIS Healthcare is the provider of targeted drug delivery and infusion care. The Ripoff Report allows you a central place to enter complaints about companies or individuals who are fraudulent, scamming or ripping people off. BOND PHARMACY INC. Generally, the rule "requires, at a minimum, that a plaintiff set forth the who, what, when, where, and how of the alleged fraud." Id. Ridgeland, MS 39157. miles away. to Dismiss [57] at 11-12; [46] 31. The mailing address for Advanced Infusion Solutions is 623 Highland Colony Parkway, Suite 100, Ridgeland, Mississippi - 39157-6077 (mailing address contact number - 877-443-4006). AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC . February 7, 2022. Corp. v. Twombly,550 U.S. 544, 556 (2007)). Appeal from the United States District Court . 3:11 . Id. texts to send an aries man Search. Further, "[t]he existence of another adequate remedy does not preclude a declaratory judgment that is otherwise appropriate." The medication in the pump lasts between a week and several months without requiring the patient to see a healthcare provider. United States District Court, S.D. ADVANCED INFUSION SOLUTIONS. Phone/Fax numbers are the same for each location: Phone: 360-933-4892 Toll Free: 888-960-1873 Fax: 360-933-1197. Want justice!? Redaction Request due 7/27/2021. See Order [61]. 1:23-CV-00409 | 2023-01-27, U.S. District Courts | Other | Escamilla v. Blue Cross Blue Shield of Michigan, d/b/a BCBSM, Wilber v. Compcare Health Services Insurance Corp et al, Mills v. Blue Cross Blue Shield Association et al, Nichols v. Blue Cross Blue Shield of Michigan, Michigan Catastrophic Claims Association v. Steadfast Insurance Company, Bradley v. Blue Cross Blue Shield of Michigan, Display Pack, Inc. v. LEL International, Inc. et al, Romano v. Blue Cross Blue Shield of Michigan. The parties do not dispute that there was a valid and binding contract between the two. Advanced Infusion Services | 114 seguidores en LinkedIn. 39, 40, 41, 42. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. [9659120-2] Initial AA Check Due satisfied. [21-30534] (SEP) [Entered: 09/15/2021 03:32 PM], APPEARANCE FORM FILED by Attorney Timothy Richardson for Appellant Randy Denning in 21-30534.